On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By Jun. 16, the…
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…
On March 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…